Related Experiment Videos
Aluminum-triggered structural modifications and aggregation of beta-amyloids
F Ricchelli1, D Drago, B Filippi
1CNR Institute of Biomedical Technologies, Metalloproteins Unit, Department of Biology, University of Padova, Viale G. Colombo, 3-35121, Padova, Italy.
Cellular and Molecular Life Sciences : CMLS
|July 2, 2005
Summary
Aluminum (Al3+) significantly promotes beta-amyloid (Abeta) aggregation and fibril formation, potentially contributing to cell dysfunction. Desferrioxamine mesylate (DFO) can reverse these effects in solution, suggesting a protective role.
Area of Science:
- Biochemistry
- Neuroscience
- Materials Science
Background:
- Beta-amyloid (Abeta) aggregation is central to Alzheimer's disease pathogenesis.
- Investigating the role of metal ions in Abeta aggregation is crucial for understanding disease mechanisms.
Purpose of the Study:
- To elucidate the structural effects of aluminum (Al3+) on Abeta(1-40) and Abeta(1-42) fragments.
- To compare the aggregation-promoting capabilities of Al3+ with other metal ions like Zn2+ and Cu2+.
- To assess the impact of Al3+-Abeta complexes on membrane models and the potential protective role of desferrioxamine mesylate (DFO).
Main Methods:
- Spectroscopic analysis to determine structural changes in Abeta peptides.
- Liposome-based assays to model cell membrane interactions.
- Comparative studies with different metal ions (Al3+, Zn2+, Cu2+).
Main Results:
- Al3+ induced beta-sheet enrichment and formation of hydrophobic clusters in Abeta peptides.
- Al3+-Abeta(1-42) formed fibrillar aggregates, while Zn2+ and Cu2+ were less effective.
- Al3+-Abeta complexes significantly altered liposome structure, indicating potential for cell dysfunction.
- DFO abolished Al3+ effects in solution but not on liposomes.
Conclusions:
- Al3+ is a potent inducer of Abeta aggregation and fibrillogenesis, surpassing Zn2+ and Cu2+.
- Al3+-Abeta complexes can disrupt cell membrane integrity, suggesting a role in neurodegeneration.
- DFO shows potential as a therapeutic agent by inhibiting Al3+-induced Abeta aggregation in extracellular spaces.